Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...

EADaily, January 6th, 2026. After the high-profile political events, 2025 was supposed to be a calmer and somewhat ...

Marvell (MRVL) gets a Buy: undervalued AI data center play with custom networking growth, plus key risks (China, capex, ...

The 2025 US National Security Strategy shifts the United States decisively away from expansive regional engagement in the ...

Russia’s manipulation of history has evolved from symbolic memory politics into a deliberate instrument of state power aimed ...